pentobarbital will reduce the extent or effect of lorlatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism.pentobarbital and olopatadine intranasal equally maximize sedation. Avoid or Use Alternate Drug. Coadministration will increase hazard of CNS despair, which can lead to additive impairment of psychomotor performance and lead to dayt… Read More